Intelligent Bio Solutions Secures Major Drug Testing Tender with Leading London Transport Operator

NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced it has secured a major contract with one of London's largest public transport operators, spanning 14 operational sites in greater London and employing over 4,400 staff. Some of the statements in this release are forward-looking statements within the meaning of Section 27A of the Securit ...